Variant report

Variant	esv995571
Chromosome Location	chr10:98833033-98840400
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:98840394..98840907-chr10:98966964..98967694,2	MCF-7	breast:
2	chr10:98832792..98833549-chr10:98877399..98877991,2	K562	blood:
3	chr10:98832312..98833311-chr10:98969943..98970883,4	MCF-7	breast:
4	chr10:98832501..98833370-chr10:98969951..98970951,5	K562	blood:
5	chr10:98832441..98833621-chr10:98876782..98877820,10	MCF-7	breast:
6	chr10:98832347..98833305-chr10:98969570..98970861,6	MCF-7	breast:
7	chr10:98832712..98833218-chr10:98993851..98994375,2	MCF-7	breast:
8	chr10:98833592..98834496-chr10:98970236..98971005,2	K562	blood:

No data

Extended variants
information (count: 277 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:277 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567591031	chr10:98833055-98833056	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs547233737	chr10:98833069-98833070	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs568285864	chr10:98833082-98833083	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs186738102	chr10:98833200-98833201	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs533070714	chr10:98833234-98833235	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs191201985	chr10:98833243-98833244	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs569695675	chr10:98833269-98833270	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs537021993	chr10:98833304-98833305	Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs549083316	chr10:98833515-98833516	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs567615444	chr10:98833521-98833522	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs535854226	chr10:98833575-98833576	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs560836133	chr10:98833598-98833599	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs553289100	chr10:98833602-98833603	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs578226015	chr10:98833619-98833620	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs539323184	chr10:98833653-98833654	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs557814019	chr10:98833667-98833668	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs576127880	chr10:98833670-98833671	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs543406073	chr10:98833672-98833673	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs561774364	chr10:98833713-98833714	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs573605941	chr10:98833716-98833717	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs541264855	chr10:98833744-98833745	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs116159132	chr10:98833761-98833762	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs533287673	chr10:98833779-98833780	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs551287232	chr10:98833809-98833810	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs563210741	chr10:98833816-98833817	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs530823360	chr10:98833846-98833847	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs548919671	chr10:98833850-98833851	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs184126771	chr10:98833882-98833883	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs567795693	chr10:98833889-98833890	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs528569072	chr10:98833932-98833933	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs138349373	chr10:98833939-98833940	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs74152134	chr10:98833955-98833956	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs112189824	chr10:98833971-98833972	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs557701864	chr10:98834060-98834061	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs112420208	chr10:98834073-98834074	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs538357212	chr10:98834075-98834076	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs537044920	chr10:98834091-98834092	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs557884379	chr10:98834098-98834099	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs555063830	chr10:98834111-98834112	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs58423228	chr10:98834124-98834125	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs77917773	chr10:98834143-98834144	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs370185635	chr10:98834149-98834150	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs539439334	chr10:98834171-98834172	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs577433718	chr10:98834220-98834221	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs577813929	chr10:98834268-98834269	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs544766828	chr10:98834353-98834354	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs113523587	chr10:98834359-98834360	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs56255957	chr10:98834384-98834385	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs113984744	chr10:98834395-98834396	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs114759177	chr10:98834417-98834418	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Paraganglioma	17535989	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Glioblastoma multiforme	17002787	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21364760	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	16608533	CNVD
Glioblastoma multiforme	22286061	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Lung cancer	16773561	CNVD
Colorectal cancer	16912164	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Autosomal dominant partial epilepsy	18472482	CNVD
Breast cancer	16397240	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:152 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:98819400-98838400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr10:98826400-98835400	Weak transcription	HUES48 Cell Line	embryonic stem cell
3	chr10:98827200-98834000	Weak transcription	Brain Angular Gyrus	brain
4	chr10:98828400-98834400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr10:98832200-98835400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
6	chr10:98832200-98836400	Enhancers	Fetal Brain Male	brain
7	chr10:98832400-98833400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr10:98832400-98833400	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr10:98832400-98835000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr10:98832400-98835200	Enhancers	Brain Germinal Matrix	brain
11	chr10:98832400-98836000	Enhancers	Fetal Brain Female	brain
12	chr10:98832600-98834800	Enhancers	Brain Inferior Temporal Lobe	brain
13	chr10:98832800-98833200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr10:98832800-98833200	Enhancers	Brain Hippocampus Middle	brain
15	chr10:98832800-98833200	Bivalent Enhancer	Fetal Lung	lung
16	chr10:98832800-98833200	Bivalent Enhancer	Fetal Muscle Leg	muscle
17	chr10:98832800-98833200	Bivalent Enhancer	Fetal Stomach	stomach
18	chr10:98832800-98833200	Enhancers	Fetal Thymus	thymus
19	chr10:98832800-98833200	Enhancers	Skeletal Muscle Female	skeletal muscle
20	chr10:98832800-98835200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr10:98833000-98833200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
22	chr10:98833000-98833200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
23	chr10:98833000-98833200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr10:98833000-98833200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr10:98833000-98833200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr10:98833000-98833200	Bivalent Enhancer	Adipose Nuclei	Adipose
27	chr10:98833000-98833200	Enhancers	Brain Cingulate Gyrus	brain
28	chr10:98833000-98833200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
29	chr10:98833000-98833200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
30	chr10:98833000-98833400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr10:98833000-98833400	Enhancers	HMEC	breast
32	chr10:98833000-98833600	Enhancers	Brain Anterior Caudate	brain
33	chr10:98833000-98833600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr10:98833000-98833800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
35	chr10:98833200-98833400	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
36	chr10:98833200-98833400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
37	chr10:98833200-98834400	Weak transcription	Brain Hippocampus Middle	brain
38	chr10:98833200-98834800	Weak transcription	Fetal Thymus	thymus
39	chr10:98833200-98839400	Weak transcription	Brain Cingulate Gyrus	brain
40	chr10:98833400-98834000	Bivalent Enhancer	Fetal Stomach	stomach
41	chr10:98833400-98834600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr10:98833600-98833800	Weak transcription	Brain Anterior Caudate	brain
43	chr10:98833600-98836000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
44	chr10:98833800-98834000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
45	chr10:98833800-98834000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
46	chr10:98833800-98834000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
47	chr10:98833800-98834000	Bivalent Enhancer	Hela-S3	cervix
48	chr10:98833800-98834200	Enhancers	Brain Anterior Caudate	brain
49	chr10:98833800-98835200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
50	chr10:98834000-98834200	Weak transcription	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links